Joint Sarcoma Research Centre

We have been driving pioneering research for innovative treatments for sarcomas since our launch in January 2019. We're a virtual research centre and a collaboration between the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.

What are sarcomas 

Sarcomas are a group of more than 100 different rare cancer types that affect connective tissue, such as muscle and fat.

Who do sarcomas affect 

Sarcomas represent one per cent of cancers in adults, but 15 per cent of cancers in children and young people – and they are associated with considerable morbidity and mortality. Survival rates haven’t improved in decades, so there is a pressing need to develop new treatment and individualised therapy.

Our research into sarcomas

The Joint Sarcoma Research Centre includes scientists and clinicians who are active in sarcoma research across our two organisations. Our co-directors are:

• Professor Janet Shipley, Head of the ICR's Division of Molecular Pathology, and
• Professor Robin Jones, Head of the Royal Marsden Sarcoma Unit, Consultant Medical Oncologist at The Royal Marsden and leader of the Sarcoma Clinical Trials Team at the ICR.

Our Deputy Director is Dr Paul Huang, leader of the ICR's Molecular and Systems Oncology Team.